If you have school-age clients with cochlear implants, you've probably noticed something odd: two children with similar audiograms, similar implant ages, and similar devices can end up with wildly different spoken language outcomes. Candidacy criteria explain who gets an implant. They explain almost nothing about who thrives after. This is the gap SLPs need to understand before writing another goal that assumes the device is doing the language work.
The candidacy net has widened dramatically — and that's mostly good news
Cochlear implant candidacy has changed more in the last decade than in the two before it. The American Cochlear Implant Alliance (ACIA) now recommends referral for children with unaided pure-tone thresholds greater than 70 dB HL, word recognition scores below 50%, or simply "limited progress in language or auditory development" — even when audiometric thresholds alone wouldn't have triggered a referral under older criteria. The FDA lowered its minimum implantation age from 12 months to 9 months in 2020 for specific devices and profound losses, and has allowed expanded candidacy for single-sided deafness. CMS widened its own coverage definition in 2022, changing the "limited benefit from amplification" threshold from the 40–60% correct range to 60% or below on open-set sentence recognition — a meaningfully looser bar. None of this is a study finding; it's regulatory and clinical-guideline movement, and ASHA has publicly supported it because, in principle, more eligible children means more children with access to spoken language before the sensitive periods for auditory development close.
What "expanded criteria" actually means now: age, laterality, ANSD, and complex anatomy
The clinical literature backs up the direction of this shift, even if it doesn't measure outcomes the way the Brazilian public-program cohort does. A 2014 update on pediatric cochlear implantation describes how minimum implantation age has progressively dropped, with implantation at 12–18 months now associated with the best outcomes, and notes that candidacy has extended to children with inner ear malformation, cochlear nerve deficiency, cochlear ossification, and additional disabilities — cases that used to be considered poor candidates by default. It's explicit that these "special clinical situations... require an individualized candidacy evaluation and a complex post-implantation rehabilitation," which is a detail worth sitting with: the same paper that celebrates expanded eligibility flags that habilitation complexity rises right alongside it.
Auditory neuropathy spectrum disorder (ANSD) sits outside that 2014 framework, but the ACIA candidacy guideline addresses it directly. Because audiometric thresholds alone are often ambiguous for children with ANSD, the guideline recommends basing candidacy decisions on functional performance and parent-report measures rather than threshold testing alone — a reminder that ANSD cases need a different evaluation lens, not just a different rehabilitation plan.
A 2011 review of new candidacy criteria documents the shift from requiring bilateral profound loss to approving most devices for severe-to-profound unilateral hearing loss, plus the emergence of short electrode arrays that preserve low-frequency residual hearing for combined acoustic-electric listening. And a 2024 review tracing the chronological evolution of CI contraindications frames this as a sustained, decades-long trend: conditions once considered absolute contraindications have been steadily reclassified as manageable with individualized evaluation. Read together, these three sources describe a field that has gotten dramatically more permissive about who can receive a device. What they do not do — because it isn't their focus — is tell you whether permissive candidacy is producing better language outcomes at the population level.
The uncomfortable finding: wider eligibility doesn't guarantee better outcomes
That's where a 2024 retrospective cohort study of a public cochlear implant program in Southern Brazil becomes essential reading for any SLP who assumes "implanted" means "on track." Of 225 children implanted between 2010 and 2020, only 129 remained in the program long enough to be included in the analysis — a 42.6% loss to follow-up rate. Among those who stayed, language results below what would be expected for their hearing age were found in 59.7% of the sample on the MAIS scale and 62% on the MUSS scale. The mean age at first surgery was 40.5 months, well past the window most of the literature associates with optimal outcomes, and 77.5% of these children had received only a unilateral implant. This is one cohort, in one public health system, with a socioeconomic profile the authors describe as homogeneous — it is not a claim about cochlear implants everywhere.
It's also important to be precise about what this cohort does and doesn't show. The 96 children lost to follow-up were never assessed on the language measures, so the study did not — and could not — measure a relationship between attrition and outcome. What it does show is two things happening at once, in the same program: a high rate of loss to follow-up combined with low attendance at speech and programming sessions among those still enrolled, and poor language scores among the children who stayed. That's a co-occurrence, not a demonstrated causal chain — but a program that is losing nearly half its caseload to follow-up, and seeing low session attendance among those who remain, is plainly not delivering consistent post-implantation service to a large share of the children it implants. That's worth taking seriously on its own terms, independent of whether it directly explains the poor language scores.
Why the source of variance isn't the device
A 2023 paper arguing for language intervention instead of speech intervention in children with cochlear implants makes the case that outcome variability is not primarily a technology problem. This is a discussion piece, not an outcomes study, but its argument is worth taking on its own terms: the authors state plainly that speech-language outcomes in pediatric CI users "are not directly or exclusively linked to technology but to combinations of individual audiological, personal, technical, and habilitational factors," and that these combinations don't always favor spoken language development — sometimes creating real risk of language deprivation despite a working device. Note that the source names audiological factors alongside personal, technical, and habilitational ones; it does not rank habilitation above the others, and neither should we. Their central argument is a reframe SLPs should sit with: the goal of habilitation isn't hitting specific hearing, speech, or articulation milestones. It's building durable communication competence, because narrow skill targets have "limited socioemotional and educational contributions" on their own and don't guarantee a child can actually function independently with language. That's a direct challenge to any therapy plan built around discrete speech-sound goals for a CI user without an explicit, ongoing language-development framework underneath it.
The disagreement in the literature: is the bottleneck audiology, or what happens after implantation?
It's worth being honest that these sources don't converge into one tidy narrative. The candidacy-and-criteria literature — the 2011 and 2024 candidacy reviews, the 2014 pediatric-implantation update, plus ACIA and FDA guidance — is fundamentally optimistic about access: get more children implanted earlier, with looser criteria, and more children gain access to spoken language during the sensitive periods for auditory development. None of the three candidacy reviews actually reports population-level outcome data, though, and the specific claim about age and outcomes comes from two sources that don't quite line up: the 2014 update names 12–18 months as the window associated with the best outcomes, while ASHA's own reporting on the evidence describes children implanted before 12 months of age as showing better outcomes than peers implanted at 12–24 months. That's a genuine discrepancy about exactly when "early" is early enough — not a number you can cite as settled consensus across this literature.
The Brazil cohort study doesn't contradict that optimism directly — its patients were implanted late (mean age 40.5 months) by the standards this same literature considers optimal, so its poor outcomes could partly reflect delayed audiological access rather than habilitation failure. But the 42.6% loss to follow-up and the finding that most retained patients still scored below expected language levels can't be explained by implant age alone. The language-versus-speech intervention argument locates the bottleneck squarely in habilitation quality and consistency, independent of when or how a child qualified for surgery. Neither position is wrong; they're describing different failure points in the same pipeline, and a child can be failed by either one, or both at once. The practical implication for SLPs is that you can't infer habilitation adequacy from candidacy pathway, and you can't infer audiological adequacy from the fact that a child kept coming to sessions.
What this means for your caseload: five habilitation priorities when a child arrives already implanted
- Ask about implant age and type before you plan anything. A child implanted unilaterally at 40 months is not the same referral as a child implanted bilaterally at 10 months, even if their current audiogram profiles look similar on paper.
- Treat gaps in follow-up as a clinical red flag, not an administrative detail. In the Brazilian public-program cohort, high attrition (42.6%) and low attendance at speech and programming sessions co-occurred with poor language scores among the children who stayed enrolled. That's a pattern, not a proven cause-and-effect relationship, but it's reason enough to treat missed mapping appointments or habilitation sessions as a conversation about barriers, not just a rescheduling task.
- Build goals around language competence, not speech-sound accuracy alone. Following the case made in the language-versus-speech intervention literature, prioritize vocabulary, syntax, narrative, and pragmatic language use as the primary target, with speech production as a downstream skill rather than the finish line.
- Document habilitational factors alongside audiological ones. Device settings and thresholds matter, but so do session consistency, caregiver engagement, and language exposure at home — all factors the habilitation-focused discussion paper identifies as combining, for better or worse, to determine outcomes.
- Don't assume a complex-candidacy child will progress on a typical timeline. For children with inner ear malformation, cochlear nerve deficiency, cochlear ossification, or additional disabilities, the 2014 update is explicit that these cases require individualized, more complex post-implantation rehabilitation planning from day one. For children with ANSD specifically, the ACIA candidacy guideline recommends functional and parent-report evaluation rather than threshold testing alone — another signal that a typical CI timeline may not apply.
A candidacy-to-outcomes checklist for SLPs working with school-age CI recipients
- What was the child's age at implantation, and was it unilateral or bilateral?
- Is there a documented history of consistent audiological follow-up and device mapping, or evidence of gaps?
- Does the current IEP or treatment plan target language development explicitly, or does it focus mainly on speech-sound production?
- Are there comorbid factors (ANSD, cochlear anomaly, additional disabilities) that call for individualized milestones rather than typical-CI-user benchmarks?
- What is the caregiver's capacity for sustained language exposure and session attendance, and what support does the family need to maintain it?
Candidacy criteria will keep expanding — that trend is well documented and, by most accounts, a genuine improvement in access. But access is the floor. The Brazilian cohort, within the limits of a single public-system program, is a reminder that surgery and enrollment don't guarantee consistent follow-up or on-track language development. And the language-versus-speech intervention literature makes an argument, not yet an established finding across large samples, that your habilitation plan, your attention to follow-up consistency, and your willingness to prioritize language over isolated speech targets are among the variables that shape whether a given child's implant becomes a functional tool for spoken language. Whether or not they turn out to be the single biggest determinant, they're the ones actually within your control starting Monday morning.
